STAA - スタ―サ―ジカル (STAAR Surgical Company) スタ―サ―ジカル

 STAAのチャート


 STAAの企業情報

symbol STAA
会社名 Staar Surgical Co. (スタ―サ―ジカル)
分野(sector) Health Care   ヘルスケア
産業(industry) Ophthalmic Goods  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 スター・サージカル(STAAR Surgical Company)は、眼科用移植型レンズ及び眼内にレンズを送達するために使用される送達システムを設計・開発・生産・販売している。同社は眼手術市場セグメントで事業を展開する。主な製品は、白内障手術に使用される眼内レンズと、屈折矯正手術で使用される埋め込み型コラーマーレンズである。同社は、矯正手術と屈折矯正手術で世界中で使用されているレンズを作り、白内障を治療する手術で使用するレンズを作る。その屈折矯正手術は、眼鏡またはコンタクトレンズが治療している視覚障害(近視、遠視、乱視および老視)のタイプを矯正する。同社は米国、カナダ、日本、スペインでの直接販売、世界の残りの地域での独立した販売など、75カ国以上で製品を販売している。   スタ―サ―ジカルは、眼内に移植可能なレンズを開発、製造、販売する米国の会社。矯正や屈折矯正手術で使用されるレンズのメ―カ―である。白内障を治療する手術に使用するためのレンズも製造。同社が開発するすべてのレンズは折りたたみ可能で、手術の際、小さな切開部からも挿入可能である。主要製品のブランド名は、「STAAR」「Collamer」など。   STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery is called an Implantable Collamer® Lens or 'ICL', which includes the EVO Visian ICL™ product line. More than 1,000,000 Visian® ICLs have been implanted to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: www.discovericl.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland.
本社所在地 1911 Walker Avenue Monrovia CA 91016 USA
代表者氏名 Louis E. Silverman ルイE.シルバーマン
代表者役職名 Independent Chairman of the Board
電話番号 +1 626-303-7902
設立年月日 30225
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 353人
url www.staar.com
nasdaq_url https://www.nasdaq.com/symbol/staa
adr_tso
EBITDA EBITDA(百万ドル) 6.48900
終値(lastsale) 41.54
時価総額(marketcap) 1825489215.9
時価総額 時価総額(百万ドル) 1770.969
売上高 売上高(百万ドル) 109.32300
企業価値(EV) 企業価値(EV)(百万ドル) 1756.707
当期純利益 当期純利益(百万ドル) 9.10600
決算概要 決算概要 BRIEF: For the six months ended 29 June 2018 STAAR Surgical Company revenues increased 44% to $61M. Net income totaled $2.4M vs. loss of $3.2M. Revenues reflect China segment increase from $10.3M to $21.9M Others segment increase of 28% to $23.4M. Net Income reflects Royalty income increase of 18% to $306K (income) Interest expense decrease of 40% to $36K (expense).

 STAAのテクニカル分析


 STAAのニュース

   Is It Too Late to Buy Staar Surgical Stock?  2021/06/15 10:25:00 The Motley Fool
This company''s eye-opening surge has people wondering if it''s too late to get in on the boom.
   Analysts Are Bullish on These Healthcare Stocks: Staar Surgical Company (STAA), Collegium Pharmaceutical (COLL)  2021/06/04 12:45:08 Smarter Analyst
Theres a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Staar Surgical Company (STAA) and The post Analysts Are Bullish on These Healthcare Stocks: Staar Surgical Company (STAA), Collegium Pharmaceutical (COLL) appeared first on Smarter Analyst .
   Is STAAR Surgical a Warren Buffett Stock?  2021/06/02 11:01:00 The Motley Fool
He''d appreciate its margins and its moat.
   Foldable Intraocular Lens Market: 3 Bold Projections 2021 | Watch How Big Opportunities Rising Till 2028 : Carl Zeiss Meditec, Hoya Corporation, Staar Surgical Company, Rayner Intraocular Lenses & More  2021/05/27 15:29:36 OpenPR
Worldwide Foldable Intraocular Lens Market Analysis to 2027 is a specialized and in-depth study of the Foldable Intraocular Lens Market Industry with a focus on the global market trend. The report aims to provide an overview of global Foldable Intraocular
   Palo Alto Investors, LLC Buys eHealth Inc, Biogen Inc, Gritstone Bio Inc, Sells Staar Surgical ...  2021/05/19 00:38:28 GuruFocus
Related Stocks: EHTH , BIIB , FOLD , ALKS , GRTS , MRNS , SYRS , APRE , SNSS ,
   Broadwood Partners, L.P. Sells 48,687 Shares of STAAR Surgical (NASDAQ:STAA) Stock  2021/02/06 09:36:41 Watchlist News
STAAR Surgical (NASDAQ:STAA) major shareholder Broadwood Partners, L.P. sold 48,687 shares of STAAR Surgical stock in a transaction on Thursday, February 4th. The shares were sold at an average price of $111.15, for a total value of $5,411,560.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available […]
   Elizabeth Yeu, M.D. and K. Peony Yu, M.D. Appointed to STAAR Surgical Board of Directors  2021/01/26 15:45:00 Business Wire
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the appointments of Elizabeth Yeu, M.D., Partner, Virginia Eye Consultants, and K. Peony Yu, M.D., retired Chief Medical Officer, FibroGen Inc., to its Board of Directors, effective January 21, 2021. “The addition of Dr. Elizabeth Yeu and Dr. K. Peony Yu to our Board of Directors illustrates
   Canaccord Genuity Stick to Their Buy Rating for Staar Surgical Company By Investing.com  2021/01/11 11:05:22 Investing.com
Canaccord Genuity Stick to Their Buy Rating for Staar Surgical Company
   Bragar Eagel & Squire is Investigating Certain Officers and Directors of Peabody Energy Corporation, EQT Corporation, Exela Technologies, and STAAR Surgical and Encourages Investors to Contact the Firm - Stocks News Feed  2021/01/06 01:00:00 Stocks News Feed
NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Peabody Energy Corporation (NYSE: BTU), EQT Corporation (NYSE: EQT), Exela Technologies, Inc. (NASDAQ: XELA), and STAAR Surgical Company (NASDAQ: STAA) on behalf of long-term stockholders. More information about… Read More »Bragar Eagel & Squire is Investigating Certain Officers and Directors of Peabody Energy Corporation, EQT Corporation, Exela Technologies, and STAAR Surgical and Encourages Investors to Contact the Firm
   STAAR Surgical Reports Third Quarter 2020 Results  2020/11/04 21:01:00 Business Wire
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended October 2, 2020. Third Quarter 2020 Overview Record Quarterly Net Sales of $47.1 Million Up 21% from the Prior Year Quarter Record Quarterly ICL Sales of $41.5 Million Up 23% from the Prior Year Quarter Record Quarterly ICL Units, Up 25% from the P
   Canaccord Genuity Stick to Their Buy Rating for Staar Surgical Company By Investing.com  2021/01/11 11:05:22 Investing.com
Canaccord Genuity Stick to Their Buy Rating for Staar Surgical Company
   Bragar Eagel & Squire is Investigating Certain Officers and Directors of Peabody Energy Corporation, EQT Corporation, Exela Technologies, and STAAR Surgical and Encourages Investors to Contact the Firm - Stocks News Feed  2021/01/06 01:00:00 Stocks News Feed
NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Peabody Energy Corporation (NYSE: BTU), EQT Corporation (NYSE: EQT), Exela Technologies, Inc. (NASDAQ: XELA), and STAAR Surgical Company (NASDAQ: STAA) on behalf of long-term stockholders. More information about… Read More »Bragar Eagel & Squire is Investigating Certain Officers and Directors of Peabody Energy Corporation, EQT Corporation, Exela Technologies, and STAAR Surgical and Encourages Investors to Contact the Firm
   STAAR Surgical Reports Third Quarter 2020 Results  2020/11/04 21:01:00 Business Wire
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended October 2, 2020. Third Quarter 2020 Overview Record Quarterly Net Sales of $47.1 Million Up 21% from the Prior Year Quarter Record Quarterly ICL Sales of $41.5 Million Up 23% from the Prior Year Quarter Record Quarterly ICL Units, Up 25% from the P
   STAAR Surgical worth buying post Earnings results? Stock market Insights & financial analysis  2020/11/04 14:40:00 Stock Market Daily
STAAR Surgical announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   STAAR Surgical (NASDAQ:STAA) Rating Increased to Strong-Buy at BidaskClub  2020/10/25 05:02:49 The Lincolnian
STAAR Surgical (NASDAQ:STAA) was upgraded by investment analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a report issued on Friday, BidAskClub reports. Several other research analysts have also recently weighed in on the company. BTIG Research reaffirmed a “hold” rating on shares of STAAR Surgical in a research report on Friday, […]

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 スタ―サ―ジカル STAA STAAR Surgical Company)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)